EMISPHERE DEVELOPMENT UPDATE
Emmis Acquisition Corp. - Class A Ordinary Share (EMIS)
US:NASDAQ Investor Relations:
ir.emisphere.com
Company Research
Source: GlobeNewswire
ROSELAND, N.J., April 06, 2020 (GLOBE NEWSWIRE) -- Novo Nordisk announced the European Commission (EC) has granted marketing authorization for Rybelsus®, (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabetes to improve glycemic control as an adjunct to diet and exercise. The marketing authorization applies to all 27 European Union member states and the United Kingdom. Rybelsus® utilizes Emisphere Technologies, Inc.'s ("Emisphere" or the "Company") (OTCBB:EMIS) proprietary Eligen® SNAC Carrier Technology. A copy of Novo Nordisk's announcement can be found at https://www.novonordisk.com/media/news-details.2277630.html About Emisphere Emisphere is a drug delivery company that utilizes its proprietary Eligen® Technology to develop new oral formulations of therapeutic agents. Emisphere is currently partners with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit the Compan
Show less
Read more
Impact Snapshot
Event Time:
EMIS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EMIS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EMIS alerts
High impacting Emmis Acquisition Corp. - Class A Ordinary Share news events
Weekly update
A roundup of the hottest topics
EMIS
Sec Filings
- 11/13/25 - Form SCHEDULE
- 11/13/25 - Form SCHEDULE
- 11/4/25 - Form 10-Q
- EMIS's page on the SEC website